GlassScriptPhysician profile
Erin Elise Frederick
NPI 1134630379
$1,441.41
in general payments reported to CMS, 2019-2025
18 companies · $351 in 2025
The $351 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $85.04 · 2022: $345 · 2023: $289 · 2024: $372 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,011.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $364.60 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $362.03 | 2021-2024 | Dupixent |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $146.32 | 2024 | Lifevest |
| Medtronic, INC. | $134.23 | 2024-2025 | Propel, Nuvent, Azure Xt Dr Mri Surescan |
| Inspire Medical Systems, INC. | $101.27 | 2025 | Inspire |
| Abbott Laboratories | $39.40 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx |
| Acclarent, INC | $38.83 | 2021-2022 | |
| Galderma Laboratories, L.P. | $32.02 | 2025 | Nemluvio |
| Stryker Corporation | $32.01 | 2025 | Latera |
| Boston Scientific Corporation | $31.90 | 2023 | |
| Amarin Pharma, INC. | $24.62 | 2022 | |
| Optinose US, INC. | $24.40 | 2025 | |
| Medinc of Texas | $20.84 | 2024 | |
| Phathom Pharmaceuticals, INC. | $20.77 | 2024 | Voquezna |
| Biotissue Holdings INC. | $18.96 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $18.69 | 2022 | |
| Janssen Pharmaceuticals, INC | $18.40 | 2024 | Xarelto |
| Glaxosmithkline, LLC. | $12.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Frederick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.